ArticlePLoS neglected tropical diseases2026
Evaluation of treatment-related serological changes in Treponema pallidum subsp. endemicum infection using latex-based immunoassays, with comparison to Treponema pallidum subsp. pallidum.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTreponema pallidum subsp. endemicum (TEN), the causative agent of bejel, is a nonvenereal treponematosis that occurs mainly in arid regions such as Africa and the Middle East. Recently, sexually transmitted TEN infections have been reported outside endemic regions, but their serological characteristics and treatment responses remain unclear. METHODOLOGY/PRINCIPAL
findingsWe analyzed 6 genetically confirmed bejel patients and 9 syphilis patients in Japan. Serum treponemal (TP) and non-treponemal (RPR) antibody titers were quantified at baseline and post-treatment using latex agglutination test (LA). The analysis of antibody profiles was performed with an immunoblot assay detecting IgM and IgG antibodies against Tp47, TmpA, Tp17, and Tp15. Phylogenetic analysis based on concatenated tp0548 and tp0856 sequences identified 6 bejel cases (TEN). Changes in TP and RPR antibody titers following treatment showed no apparent difference between bejel and syphilis groups. In both groups, some IgM antibodies decreased following treatment, while some IgG antibodies increased. CONCLUSIONS/SIGNIFICANCE: The serological profiles and post-treatment changes in antibody titers were similar between bejel patients and syphilis patients. These findings suggest that conventional serological assays developed for syphilis may also be useful for clinical management of bejel, including evaluation of treatment response. This study provides new insight into the diagnosis and serological monitoring of sexually transmitted bejel cases outside endemic areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.